BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 28512253)

  • 1. Infiltrating Myeloid Cells Exert Protumorigenic Actions via Neutrophil Elastase.
    Lerman I; Garcia-Hernandez ML; Rangel-Moreno J; Chiriboga L; Pan C; Nastiuk KL; Krolewski JJ; Sen A; Hammes SR
    Mol Cancer Res; 2017 Sep; 15(9):1138-1152. PubMed ID: 28512253
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neutrophil elastase from myeloid cells promotes TSC2-null tumor growth.
    Taya M; Garcia-Hernandez ML; Rangel-Moreno J; Minor B; Gibbons E; Hammes SR
    Endocr Relat Cancer; 2020 Apr; 27(4):261-274. PubMed ID: 32045362
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epigenetic Suppression of SERPINB1 Promotes Inflammation-Mediated Prostate Cancer Progression.
    Lerman I; Ma X; Seger C; Maolake A; Garcia-Hernandez ML; Rangel-Moreno J; Ackerman J; Nastiuk KL; Susiarjo M; Hammes SR
    Mol Cancer Res; 2019 Apr; 17(4):845-859. PubMed ID: 30610107
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TLR9-Targeted STAT3 Silencing Abrogates Immunosuppressive Activity of Myeloid-Derived Suppressor Cells from Prostate Cancer Patients.
    Hossain DM; Pal SK; Moreira D; Duttagupta P; Zhang Q; Won H; Jones J; D'Apuzzo M; Forman S; Kortylewski M
    Clin Cancer Res; 2015 Aug; 21(16):3771-82. PubMed ID: 25967142
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of Vascular Endothelial Growth Factor in Ovarian Cancer Inhibits Tumor Immunity through the Accumulation of Myeloid-Derived Suppressor Cells.
    Horikawa N; Abiko K; Matsumura N; Hamanishi J; Baba T; Yamaguchi K; Yoshioka Y; Koshiyama M; Konishi I
    Clin Cancer Res; 2017 Jan; 23(2):587-599. PubMed ID: 27401249
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neutrophil elastase in the tumor microenvironment.
    Lerman I; Hammes SR
    Steroids; 2018 May; 133():96-101. PubMed ID: 29155217
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD4+ T effector memory cell dysfunction is associated with the accumulation of granulocytic myeloid-derived suppressor cells in glioblastoma patients.
    Dubinski D; Wölfer J; Hasselblatt M; Schneider-Hohendorf T; Bogdahn U; Stummer W; Wiendl H; Grauer OM
    Neuro Oncol; 2016 Jun; 18(6):807-18. PubMed ID: 26578623
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor-infiltrating monocytic myeloid-derived suppressor cells mediate CCR5-dependent recruitment of regulatory T cells favoring tumor growth.
    Schlecker E; Stojanovic A; Eisen C; Quack C; Falk CS; Umansky V; Cerwenka A
    J Immunol; 2012 Dec; 189(12):5602-11. PubMed ID: 23152559
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting YAP-Dependent MDSC Infiltration Impairs Tumor Progression.
    Wang G; Lu X; Dey P; Deng P; Wu CC; Jiang S; Fang Z; Zhao K; Konaparthi R; Hua S; Zhang J; Li-Ning-Tapia EM; Kapoor A; Wu CJ; Patel NB; Guo Z; Ramamoorthy V; Tieu TN; Heffernan T; Zhao D; Shang X; Khadka S; Hou P; Hu B; Jin EJ; Yao W; Pan X; Ding Z; Shi Y; Li L; Chang Q; Troncoso P; Logothetis CJ; McArthur MJ; Chin L; Wang YA; DePinho RA
    Cancer Discov; 2016 Jan; 6(1):80-95. PubMed ID: 26701088
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pten null prostate epithelium promotes localized myeloid-derived suppressor cell expansion and immune suppression during tumor initiation and progression.
    Garcia AJ; Ruscetti M; Arenzana TL; Tran LM; Bianci-Frias D; Sybert E; Priceman SJ; Wu L; Nelson PS; Smale ST; Wu H
    Mol Cell Biol; 2014 Jun; 34(11):2017-28. PubMed ID: 24662052
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum inhibits the immunosuppressive function of myeloid-derived suppressor cells isolated from 4T1 tumor-bearing mice.
    Hamilton MJ; Banáth JP; Lam V; Lepard NE; Krystal G; Bennewith KL
    Cancer Immunol Immunother; 2012 May; 61(5):643-54. PubMed ID: 22021068
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential Targeting of Gr-MDSCs, T Cells and Prostate Cancer Cells by Dactolisib and Dasatinib.
    Liu G; Jin Z; Lu X
    Int J Mol Sci; 2020 Mar; 21(7):. PubMed ID: 32230980
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CXCL2/MIF-CXCR2 signaling promotes the recruitment of myeloid-derived suppressor cells and is correlated with prognosis in bladder cancer.
    Zhang H; Ye YL; Li MX; Ye SB; Huang WR; Cai TT; He J; Peng JY; Duan TH; Cui J; Zhang XS; Zhou FJ; Wang RF; Li J
    Oncogene; 2017 Apr; 36(15):2095-2104. PubMed ID: 27721403
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-Fat Diet-Induced Inflammation Accelerates Prostate Cancer Growth via IL6 Signaling.
    Hayashi T; Fujita K; Nojima S; Hayashi Y; Nakano K; Ishizuya Y; Wang C; Yamamoto Y; Kinouchi T; Matsuzaki K; Jingushi K; Kato T; Kawashima A; Nagahara A; Ujike T; Uemura M; Pena MDCR; Gordetsky JB; Morii E; Tsujikawa K; Netto GJ; Nonomura N
    Clin Cancer Res; 2018 Sep; 24(17):4309-4318. PubMed ID: 29776955
    [No Abstract]   [Full Text] [Related]  

  • 15. Myeloid derived suppressor cell infiltration of murine and human gliomas is associated with reduction of tumor infiltrating lymphocytes.
    Raychaudhuri B; Rayman P; Huang P; Grabowski M; Hambardzumyan D; Finke JH; Vogelbaum MA
    J Neurooncol; 2015 Apr; 122(2):293-301. PubMed ID: 25579983
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pam2 lipopeptides systemically increase myeloid-derived suppressor cells through TLR2 signaling.
    Maruyama A; Shime H; Takeda Y; Azuma M; Matsumoto M; Seya T
    Biochem Biophys Res Commun; 2015 Feb; 457(3):445-50. PubMed ID: 25596131
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Myeloid-derived suppressor cells suppress antitumor immune responses through IDO expression and correlate with lymph node metastasis in patients with breast cancer.
    Yu J; Du W; Yan F; Wang Y; Li H; Cao S; Yu W; Shen C; Liu J; Ren X
    J Immunol; 2013 Apr; 190(7):3783-97. PubMed ID: 23440412
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Infiltrating S100A8+ myeloid cells promote metastatic spread of human breast cancer and predict poor clinical outcome.
    Drews-Elger K; Iorns E; Dias A; Miller P; Ward TM; Dean S; Clarke J; Campion-Flora A; Rodrigues DN; Reis-Filho JS; Rae JM; Thomas D; Berry D; El-Ashry D; Lippman ME
    Breast Cancer Res Treat; 2014 Nov; 148(1):41-59. PubMed ID: 25270120
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sivelestat, a specific neutrophil elastase inhibitor, suppresses the growth of gastric carcinoma cells by preventing the release of transforming growth factor-alpha.
    Wada Y; Yoshida K; Hihara J; Konishi K; Tanabe K; Ukon K; Taomoto J; Suzuki T; Mizuiri H
    Cancer Sci; 2006 Oct; 97(10):1037-43. PubMed ID: 16918998
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of Cationic Amino Acid Transporter 2 Is Required for Myeloid-Derived Suppressor Cell-Mediated Control of T Cell Immunity.
    Cimen Bozkus C; Elzey BD; Crist SA; Ellies LG; Ratliff TL
    J Immunol; 2015 Dec; 195(11):5237-50. PubMed ID: 26491198
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.